• Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
Joining the Fight Against Diabetes
24 Jul 2023

According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.

Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.

The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.

Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.

This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.

Topics:

Brands:

Related Stories

IHH Healthcare Singapore Raises Over S$40,000 for Community Support

We are proud to share that IHH Healthcare Singapore has successfully concluded a fundraising campaign in support of the Community Chest SGSHARE initiative, reaffirming our commitment to caring for the communities we serve.

24 Jul 2023
Read More

Gleneagles JPMC Empowers Young Minds with Back-to-School Assistance Programme

Gleneagles JPMC launched its first-ever Back-to-School Assistance Programme on 15 December, partnering with Majlis Kesejahteraan Masyarakat (MKM) Brunei to support 20 underprivileged students for the 2026 school year.

24 Jul 2023
Read More

Gleneagles Hong Kong Advances Cross-Border Healthcare Innovation in the Greater Bay Area

Gleneagles Hospital Hong Kong was honoured to participate in a recent forum hosted by the Greater Bay Area Medical Professional Development Association, bringing together leaders from across the healthcare ecosystem to discuss how the region can advance development amid a shifting healthcare and economic landscape.
24 Jul 2023
Read More

Gleneagles Hong Kong to Launch Groundbreaking Longevity Service

Gleneagles Hong Kong is set to transform preventive care as the city’s first hospital network to offer a groundbreaking AI-powered longevity service. 

24 Jul 2023
Read More

Fortis Leads the Way in Building a Nation of First Responders

When a cardiac emergency strikes, survival often depends on what happens in the first few minutes. Before an ambulance arrives. Before hospital doors open. In those moments, a trained bystander can mean the difference between life and loss.

24 Jul 2023
Read More

Gleneagles JPMC Collects 418kg of Waste in Beach Clean-Up Effort

Celebrate our Brunei colleagues for stepping beyond the hospital walls to make a real, measurable impact on the environment.

24 Jul 2023
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo